Oncolytics Biotech Inc. ( ONCY ), a clinical-stage immunotherapy company developing pelareorep, announced an update on its Phase 1/2 GOBLET study, including the expected timing of clinical data ...

Microsoft released an out-of-band Windows update on September 14, 2026, to fix problems introduced by its September 8 ...

Heidelberg Materials faces Nov 4 Q3 update as Deutsche Bank and RBC trim targets, while its Nordic unit moves to buy NCC ...

Oncolytics Biotech® Inc. has announced the successful completion of enrollment in its GOBLET Phase 1/2 study, alongside the ...

Lamar Jackson could return against the Browns on Sunday after an ankle injury kept him out of Baltimore's overtime win in ...

Check Point Research found two LiteLLM vulnerabilities that could let low-privilege users execute code, access sensitive ...

Completion of enrollment earlier this year and expected final PanCAN grant payment this quarter mark successful completion of a key phase of ...

Cleveland airport doubles TSA central checkpoint capacity © 2026 American City Business Journals. All rights reserved. Use of ...

BioNTech Shares Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy in Metastatic HPV16-Positive HNC / ...

MediaTek traded at a P/E ratio of 74.68 on October 13, 2026, while its trailing dividend yield was 0.01 percent. The figures ...

AHEAD-MERIT Phase 2/3 clinical trial did not meet its first dual primary endpoint of progression-free survival for the mRNA cancer immunotherapy ...

Oncolytics Biotech® Inc. provided an update on its intellectual property strategy, outlining progress on new method of use patents and plans to expand its portfolio with composition of matter ...